These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1590376

  • 1. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE, Severson DL.
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G.
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [Abstract] [Full Text] [Related]

  • 3. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE, Severson DL.
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [Abstract] [Full Text] [Related]

  • 4. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G, Cam MC, Sambandam N, Abrahani MA, Rodrigues B.
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [Abstract] [Full Text] [Related]

  • 5. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L, Severson DL.
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [Abstract] [Full Text] [Related]

  • 6. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N, Abrahani MA, St Pierre E, Al-Atar O, Cam MC, Rodrigues B.
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [Abstract] [Full Text] [Related]

  • 7. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B, Severson DL.
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [Abstract] [Full Text] [Related]

  • 8. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R, Juhasz A, Severson DL.
    Biochem J; 1990 Sep 01; 270(2):391-5. PubMed ID: 2169239
    [Abstract] [Full Text] [Related]

  • 9. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B, Braun JE, Spooner M, Severson DL.
    Can J Physiol Pharmacol; 1992 Sep 01; 70(9):1271-9. PubMed ID: 1493594
    [Abstract] [Full Text] [Related]

  • 10. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE, Severson DL.
    Lipids; 1993 Jan 01; 28(1):59-61. PubMed ID: 8383273
    [Abstract] [Full Text] [Related]

  • 11. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D, Kuo KH, Abrahani A, An D, Qi Y, Heung J, Kewalramani G, Pulinilkunnil T, Ghosh S, Innis SM, Rodrigues B.
    Cardiovasc Res; 2006 Oct 01; 72(1):124-33. PubMed ID: 16934788
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
    Ewart HS, Carroll R, Severson DL.
    Can J Physiol Pharmacol; 1999 Aug 01; 77(8):571-8. PubMed ID: 10543720
    [Abstract] [Full Text] [Related]

  • 13. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L, Severson DL.
    Can J Physiol Pharmacol; 1996 Nov 01; 74(11):1204-9. PubMed ID: 9028578
    [Abstract] [Full Text] [Related]

  • 14. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B, Spooner M, Severson DL.
    Am J Physiol; 1992 Feb 01; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [Abstract] [Full Text] [Related]

  • 15. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N, Lim F, Cam MC, Rodrigues B.
    J Cardiovasc Pharmacol; 1997 Jul 01; 30(1):110-7. PubMed ID: 9268229
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG, Evans RD.
    Am J Physiol Endocrinol Metab; 2008 Nov 01; 295(5):E1106-16. PubMed ID: 18780778
    [Abstract] [Full Text] [Related]

  • 17. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL, Lee M, Carroll R.
    Mol Cell Biochem; 1988 Jan 01; 79(1):17-24. PubMed ID: 3374475
    [Abstract] [Full Text] [Related]

  • 18. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N, Abrahani MA, Craig S, Al-Atar O, Jeon E, Rodrigues B.
    Am J Physiol Heart Circ Physiol; 2000 Jun 01; 278(6):H1874-82. PubMed ID: 10843884
    [Abstract] [Full Text] [Related]

  • 19. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
    Ramírez I, Severson DL.
    Biochem J; 1986 Aug 15; 238(1):233-8. PubMed ID: 3800935
    [Abstract] [Full Text] [Related]

  • 20. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T, Halimi O, Ben-Naim M, Stein O, Stein Y.
    Biochim Biophys Acta; 1989 Nov 20; 1014(2):178-83. PubMed ID: 2554975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.